Adaptimmune’s $125 Million Debt Financing with Hercules Capital

Ropes & Gray advised Adaptimmune Therapeutics plc on the transaction, and DLA Piper advised Hercules Capital.Adaptimmune Therapeutics plc (NASDAQ: ADAP), a clinical-stage biopharmaceutical company, announced a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now